↓ Skip to main content

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
Published in
Cochrane database of systematic reviews, July 2023
DOI 10.1002/14651858.cd006910.pub3
Authors

Rebecca Newhouse, Ellen Nelissen, Karim Hussien El-Shakankery, Ewelina Rogozińska, Esme Bain, Susana Veiga, Jo Morrison

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 24%
Unspecified 1 6%
Professor > Associate Professor 1 6%
Other 1 6%
Student > Master 1 6%
Other 0 0%
Unknown 9 53%
Readers by discipline Count As %
Medicine and Dentistry 4 24%
Nursing and Health Professions 1 6%
Unspecified 1 6%
Decision Sciences 1 6%
Engineering 1 6%
Other 0 0%
Unknown 9 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2023.
All research outputs
#3,845,274
of 24,225,722 outputs
Outputs from Cochrane database of systematic reviews
#6,400
of 12,874 outputs
Outputs of similar age
#48,180
of 287,799 outputs
Outputs of similar age from Cochrane database of systematic reviews
#52
of 117 outputs
Altmetric has tracked 24,225,722 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,874 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.9. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,799 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.